Skip to content

COVID-19 Related Health and Infection Control Practices Among Dentists

COVID-19 Related Health and Infection Control Practices Among Dentists

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04423770
Enrollment
2196
Registered
2020-06-09
Start date
2020-06-08
Completion date
2021-06-08
Last updated
2021-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2

Keywords

SARS-CoV-2, COVID-19, survey, dentistry, infection control

Brief summary

As dentists begin reopening their practices during a global pandemic, the risk of COVID-19 infection that dentists face in providing dental care remains unknown. Estimating the occupational risk of COVID-19, and producing evidence on the types of infection control practices and dental practices that may affect COVID-19 risk, is therefore imperative. The goal of the proposed study is to understand U.S.-based dentists' health and dental-practice reactions to COVID-19. To estimate this, U.S-based dentists will be surveyed monthly. These findings could be used to describe the prevalence and incidence of COVID-19 among dentists, determine what infection control steps dentists take over time, and estimate whether infection control adherence in dental practice is related to COVID-19 incidence.

Interventions

OTHERNo intervention

No intervention; this is a purely observational study

Sponsors

American Dental Association
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Primary dental practice is in United States * 18 years of age or older * Dentist

Exclusion criteria

•Answered no to ADA survey sent May 2020 that read As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols.

Design outcomes

Primary

MeasureTime frameDescription
COVID-19 probable or confirmed case18 monthsCOVID-19 case as confirmed by clinician and/or detection of SARS-CoV-2 RNA or a specific antigen in a clinical specimen

Secondary

MeasureTime frameDescription
Anxiety12 monthsAssessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater anxiety.
Depression12 monthsAssessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4). Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater depressive symptoms.
Dental practice infection control efforts12 monthsSelf-reports of infection control efforts in the respondents' primary dental practices
Dentists' use of personal protective equipment12 monthsSelf-reports of personal protective equipment use

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026